Storm Therapeutics' Series A - II Round

Storm Therapeutics raised a round of funding on January 08, 2018. Investors include Taiho Ventures.

Storm Therapeutics, is a spin-out company from the University of Cambridge's Gurdon Institute focused on the identification and development of small molecule drugs that target RNA-modifying enzymes, o…

Articles about Storm Therapeutics' Series A - II Round: